A Phase 1 Single Centre Single-Blind Randomised Placebo-Controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral AZD3355 After Administration of Single Ascending Doses and Multiple Repeated Doses in Healthy Male Volunteers.

Trial Profile

A Phase 1 Single Centre Single-Blind Randomised Placebo-Controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral AZD3355 After Administration of Single Ascending Doses and Multiple Repeated Doses in Healthy Male Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Dec 2010

At a glance

  • Drugs Lesogaberan (Primary)
  • Indications Gastro-oesophageal reflux
  • Focus Adverse reactions
  • Sponsors AstraZeneca
  • Most Recent Events

    • 06 Dec 2010 Actual end date changed from Jan 2009 to Dec 2008 as reported by ClinicalTrials.gov.
    • 23 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 29 Sep 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top